Quantum-Si incorporated (NASDAQ:QSI) CFO Purchases $43,500.00 in Stock

Quantum-Si incorporated (NASDAQ:QSI) CFO Jeffry R. Keyes bought 50,000 shares of the company’s stock in a transaction dated Friday, August 9th. The stock was purchased at an average cost of $0.87 per share, for a total transaction of $43,500.00. Following the completion of the acquisition, the chief financial officer now owns 446,820 shares in the company, valued at approximately $388,733.40. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Quantum-Si Stock Performance

Shares of QSI opened at $1.02 on Friday. The firm has a market cap of $144.65 million, a P/E ratio of -1.57 and a beta of 2.89. Quantum-Si incorporated has a 52 week low of $0.73 and a 52 week high of $2.47. The firm’s 50-day simple moving average is $1.08 and its 200 day simple moving average is $1.50.

Wall Street Analyst Weigh In

Separately, HC Wainwright reissued a “buy” rating and set a $4.00 price target on shares of Quantum-Si in a research report on Friday, May 10th.

Institutional Trading of Quantum-Si

Several institutional investors have recently added to or reduced their stakes in QSI. XTX Topco Ltd bought a new stake in Quantum-Si in the 2nd quarter valued at about $25,000. Public Employees Retirement System of Ohio acquired a new stake in shares of Quantum-Si in the first quarter valued at approximately $27,000. Bleakley Financial Group LLC bought a new stake in shares of Quantum-Si in the first quarter valued at approximately $28,000. Simplicity Wealth LLC acquired a new stake in Quantum-Si during the first quarter worth approximately $28,000. Finally, Virtu Financial LLC bought a new position in Quantum-Si during the 1st quarter worth $98,000. 39.90% of the stock is currently owned by institutional investors.

About Quantum-Si

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.